| http://www.w3.org/ns/prov#value | - such statements would be minimal, considering the lack of other attractive treatment options,??? says Schwartz, who rates the stock a buy and has a $35 a share price target.In case there was any doubt, CEO Watkins told analysts and investors at a conference yesterday that 2011 is a turning point for the money-losing company.
|
